![Pediatric News](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/244/normal/Screen_Shot_2014-10-28_at_17.05.31.png?1414515960)
New Drug Approvals Are the Wrong Metric for Cancer Policy
Pediatric News ,
How should we define success in cancer policy — what should the endpoint be? It’s debatable.
How should we define success in cancer policy — what should the endpoint be? It’s debatable.
How should we define success in cancer policy — what should the endpoint be? It's debatable.
Listen with Speechify Register for free to listen to this article Thank you. Listen to this article using the player above.
5 minutesmins 5 minutesmins Share Photo/Shutterstock The biotech industry is on the brink of a potential recovery in 2024.